When was SolasCure founded?

SolasCure was founded in 2017 and raised its 1st funding round 4 years after it was founded.

Where is SolasCure located?

SolasCure is headquartered in Cambridge, United Kingdom. It is registered at Wellington House, East Road, Cambridge, England, CB1 1BH.

Which legal entities is SolasCure associated with?

SolasCure is associated with Solascure Limited.

How many employees does SolasCure have?

As of Jun 30, 2026, the latest employee count at SolasCure is 17.

Is SolasCure a funded company?

SolasCure is a funded company, having raised a total of $34.1M across 4 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Aug 10, 2021.

When was the latest funding round of SolasCure?

SolasCure's latest funding was a $***** Grant (prize money) round on Mar 20, 2024, with participation from 1 investor. Its primary sector is Wound Care. Globally, the Wound Care sector has seen $72.9M in funding in 2026 to date.

Where does SolasCure rank among its competitors?

SolasCure ranks 1st amongst 207 active competitors, of which 44 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was BioStem Technologies, which secured $2.5M in May, 2026.

Who are the top competitors of SolasCure?

SolasCure's top competitors include SanuWave, Nuo Therapeutics and Sanara MedTech. Among them, BioStem Technologies secured the most recent funding round in May, 2026.

SolasCure - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Developer of biologic therapies for the treatment of chronic wounds. This therapy utilizes enzymatic debridement to prepare the wound bed while activating endogenous repair pathways to facilitate healing. The treatment is designed to address biological barriers that prevent tissue regeneration in patients with persistent wounds.

Website: www.solascure.com/
Social
Email ID: *****@solascure.com
Phone Number: +44 **********
Registered Address: Wellington House, East Road, Cambridge, England, CB1 1BH

Key Metrics

Founded Year

2017

Location

Cambridge, United Kingdom

Stage

Series B

Total Funding

$34.1M in 4 rounds

Latest Funding Round

Grant (prize money), Mar 20, 2024, $*****

Investors

Seneca & 67 more

Ranked

1^st among 207 active competitors

Employee Count

17 as on Jun 30, 2026

Similar Companies

SanuWave & 240 more

View SolasCure's full profile

SolasCure is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Solascure Limited CIN: 10826246 , United Kingdom, Active	Jun 19, 2017	-	10 (As on Jun 30, 2025)

SolasCure has raised a total funding of $34.1M over 4 rounds. Its first funding round was on Aug 10, 2021. Its latest funding round was a Grant (prize money) round on Mar 20, 2024 for $*****. 1 investor participated in its latest round. SolasCure has 29 institutional investors and 39 angel investors.

Here is the list of recent funding rounds of SolasCure:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 20, 2024	5244829	Grant (prize money)	6894477	3423864	7091633	3748665
Mar 27, 2023	1255693	Series B	5564093	2795684	2966686	BRAIN & 3 more
2022	4130	Grant (prize money)	1207	1926	5120	EIC Fund

Access funding benchmarks and valuations. Sign up today!

View details of SolasCure's funding rounds and investors

The founders of SolasCure is Sam Bakri. Lee Harle is the CEO of SolasCure.

Here are the details of SolasCure's key team members:

Sam Bakri: Former Founder of SolasCure and founder of 1 other company.
Lee Harle: CEO of SolasCure.
Contact Info: 1 email address

SolasCure's Board of Directors

SolasCure's board has 6 active members. Daniel Patrick Wright, Jane Kristin Hart, Andreas Weymann, Adriaan Jacobus Francois Moelker, Frank Goebel and Riad Mounir Riad Armanious are independent board members.

Here is the list of SolasCure's board of directors:

Name	Type	Representing	Status	Duration
Daniel Patrick Wright	Independent board member	-	Current	7y 11m
escoupu	Independent board member	-	Current	6y 8m
n{hdogg	Independent board member	-	Current	2y 9m
bsarorm	Independent board member	-	Current	2y 2m
lgasehx	Independent board member	-	Current	2y 1m
jcspjiu	Independent board member	-	Current	1y 8m

View details of SolasCure's Founder profiles and Board Members

SolasCure's employee count trend

SolasCure has 17 employees as of Jun 26. Here is SolasCure's employee count trend over the years:

Uncover SolasCure's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of SolasCure include SanuWave, Nuo Therapeutics and Sanara MedTech. Here is the list of Top 10 competitors of SolasCure, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	SolasCure 2017, Cambridge (United Kingdom), Series B	Developer of biologic therapies for the treatment of chronic wounds	$34.1M	Innovate UK, IQ-EQ & 66 others	62/100
2nd	SanuWave 2005, Alpharetta (United States), Public	Developer of Noninvasive devices, and biologics for wound healing	$1.43M	CIT, Kingswood Capital Markets	60/100
3rd	Nuo Therapeutics 2001, Gaithersburg (United States), Public	Developer of regenerative products for wound care	$69.1M	MidCap Financial, Maryland Department of Commerce ... & 2 others	57/100
4th	Sanara MedTech 1982, Fort Worth (United States), Public	Developer of therapeutics for infectious disease	-	BlueIO, The Catalyst Group	56/100
5th	TargED 2020, Utrecht (Netherlands), Series A	Developer of biological drugs for the treatment of thrombosis	$82.8M	Andera Partners, Sunstone & 8 others	56/100
6th	MediWound 2001, Yavne (Israel), Public	Developer of enzymatic therapeutic solutions for tissue repair and regeneration	$18M	Point72, New Era Capital Partners & 10 others	54/100
7th	Tissue Regenix 2006, Swillington (United Kingdom), Public	Developer of regenerative medical devices by using cell technology	-	Harwood Capital, IP Group & 2 others	53/100
8th	Next Science 2012, Jacksonville (United States), Public	Redefining healing through science, innovation, and commitment to better patient outcomes	-	-	51/100
9th	BioStem Technologies 2006, Pompano Beach (United States), Public	Provider of placental-based amniotic tissue products	-	-	51/100
10th	Cambium Bio 2007, Paddington (Australia), Public	Developer of therapeutics for ophthalmology and tissue regeneration	-	HHS, Zheng Yang Biomedical Technology & 1 others	49/100